199 related articles for article (PubMed ID: 24286961)
21. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
Waksman R; Pakala R
EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
[TBL] [Abstract][Full Text] [Related]
22. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
[TBL] [Abstract][Full Text] [Related]
23. Stent thrombosis--risk assessment and prevention.
Motovska Z; Knot J; Widimsky P
Cardiovasc Ther; 2010 Oct; 28(5):e92-100. PubMed ID: 20553282
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
25. Drug-eluting stents for coronary artery disease: a review.
Martin DM; Boyle FJ
Med Eng Phys; 2011 Mar; 33(2):148-63. PubMed ID: 21075668
[TBL] [Abstract][Full Text] [Related]
26. Drug-eluting stents: a comprehensive appraisal.
Butt M; Connolly D; Lip GY
Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
[TBL] [Abstract][Full Text] [Related]
28. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
[TBL] [Abstract][Full Text] [Related]
29. The pathophysiology and burden of restenosis.
Weintraub WS
Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
31. New developments in coronary stent technology.
Smith EJ; Jain AK; Rothman MT
J Interv Cardiol; 2006 Dec; 19(6):493-9. PubMed ID: 17107363
[TBL] [Abstract][Full Text] [Related]
32. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
[TBL] [Abstract][Full Text] [Related]
33. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
[TBL] [Abstract][Full Text] [Related]
34. Bare metal stent implantation for in-stent restenosis with a drug-eluting stent.
Matsuoka H; Kawakami H; Ohshita A; Kohno T; Shigemi S; Okayama H; Higaki J
J Cardiol; 2010 Jan; 55(1):135-8. PubMed ID: 20122561
[TBL] [Abstract][Full Text] [Related]
35. Developments in coronary artery stenting: primum non nocere.
Simsek C; Serruys PW
Panminerva Med; 2011 Mar; 53(1):19-30. PubMed ID: 21346701
[TBL] [Abstract][Full Text] [Related]
36. Coronary stenting with a novel stainless steel balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model.
Carter AJ; Laird JR; Kufs WM; Bailey L; Hoopes TG; Reeves T; Farb A; Virmani R
J Am Coll Cardiol; 1996 Apr; 27(5):1270-7. PubMed ID: 8609355
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
38. Self-expanding intracoronary stents in the treatment of coronary artery disease: new developments and future directions.
Lu H; Grundeken MJ; Koch KT; Wykrzykowska JJ
Minerva Cardioangiol; 2013 Oct; 61(5):547-62. PubMed ID: 24096249
[TBL] [Abstract][Full Text] [Related]
39. [The bioresorbable coronary scaffold].
Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
[TBL] [Abstract][Full Text] [Related]
40. Stent versus off-pump coronary bypass grafting in the second-generation drug-eluting stent era.
Yi G; Joo HC; Youn YN; Hong S; Yoo KJ
Ann Thorac Surg; 2013 Aug; 96(2):535-41. PubMed ID: 23622702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
